Market cap
$2,075 Mln
Revenue (TTM)
$699 Mln
P/E Ratio
--
P/B Ratio
6.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 5.47 | 15.60 | 10.95 | 11.26 | 5.12 |
| EBIT | -- | -- | -37.73 | 4.47 | -254.78 |
| Net Profit | 77.99 | 60.99 | 13.09 | 4.71 | -298.12 |
| EPS | 78.34 | 62.48 | 16.21 | 6.44 | -287.72 |
| Book Value | -- | -- | -8.56 | -10.08 | -6.65 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -25.92 | -20.54 | -19.79 | -20.79 | -19.96 |
| Net Margin
| -- | -- | -21.25 | -- | -- |
| Return on equity
| -45.69 | -34.39 | -43.79 | -38.89 | -46.67 |
| Return on Capital
| -17.81 | -13.61 | -- | -16.28 | -16.84 |
| Return on Assets
| -15.05 | -11.69 | -9.87 | -13.32 | -14.13 |
| Debt to Equity (x)
| -- | -- | 0.58 | 0.85 | 1.90 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
-16.28
|
-16.84
|
-20.31
|
-8.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-43.79
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-43.79
|
-38.89
|
-46.67
|
-51.52
|
-21.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-9.87
--
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-9.87
|
-13.32
|
-14.13
|
-17.71
|
-7.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-19.79
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-19.79
|
-20.79
|
-19.96
|
-36.99
|
-16.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-21.25
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-21.25
|
-20.79
|
-27.86
|
-40.65
|
-17.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
10.95
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
10.95
|
0.08
|
0.19
|
-0.05
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-37.73
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-37.73
|
-12.77
|
35.88
|
-110.47
|
-101.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
13.09
--
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
13.09
|
19.21
|
18.55
|
-123.75
|
-58.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
16.21
--
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
16.21
|
0.22
|
0.19
|
-1.20
|
-0.57
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Book Value Growth
-6.95
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-6.95
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.58
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
0.58
|
0.85
|
1.90
|
1.64
|
1.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
0.03
|
1.57
|
0.23
|
0.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.89
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
2.89
|
2.90
|
1.46
|
5.78
|
7.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
2.70
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
2.70
|
2.71
|
1.42
|
5.56
|
6.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-62.65
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-62.65
|
-8.00
|
-10.36
|
-38.41
|
-26.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
20.86
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
20.86
|
17.60
|
16.87
|
15.14
|
20.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.46
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
0.46
|
0.64
|
0.51
|
0.44
|
0.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
60.59
|
54.07
|
67.89
|
75.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
83.39
|
97.50
|
96.14
|
85.54
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
248.77
|
265.56
|
255.67
|
250.88
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
-104.79
|
-113.99
|
-91.65
|
-89.68
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
-10.58
|
-19.06
|
-7.71
|
-83.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
6.20
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
6.20
|
4.23
|
8.92
|
4.41
|
17.46
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-6.92
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
-6.92
|
-10.70
|
-26.80
|
-7.23
|
-93.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
2,075
--
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Novocure (NVCR)
|
2,075
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|